Inventor · disambiguated record
Shunsuke Takenaka
Also filed as: TAKENAKA SHUNSUKE
3 granted patents·3 pending applications·12 citations·filing 2018–2024
62Inventor score
Files withAMGEN INC6
Top patents by PatentIndex Score
6 records- 0191US11541103B2Interleukin-21 mutein/ anti-PD-1 antibody conjugatesAMGEN INC·Filed 2018·Granted Jan 3, 2023·7 cites·34 claims
- 0287US11518808B2Anti-PD-1 antibodies and methods of treatmentAMGEN INC·Filed 2019·Granted Dec 6, 2022·5 cites·21 claims
- 0368US2023381276A1Interleukin-21 mutein/ anti-pd-1 antibody conjugatesAMGEN INC·Filed 2022·Application pending·0 cites
- 0464US2024150481A1Mesothelin-targeted cd40 agonistic multispecific antibody constructs for the treatment of solid tumorsAMGEN INC·Filed 2024·Application pending·0 cites
- 0552US11926672B2Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumorsAMGEN INC·Filed 2020·Granted Mar 12, 2024·0 cites·35 claims
- 0646US2021301020A1Combination of lilrb1/2 pathway inhibitors and pd-1 pathway inhibitorsAMGEN INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →